Community Pharmacy: Is the PBM Evolving Toward New Delivery Models? What Does this Mean for the Industry?
As the healthcare industry continues to rapidly shift and evolve, so too does the pharmacy benefit manager (PBM) niche. There are a handful of key issues and trends that are fueling these changes — from pharma mega-mergers to value-based care efforts to demands for...
What to Expect with 340B in 2019 – The Debate’s Not Over
At AlliantRx, we know drug pricing remains a top priority for you, your pharmacy’s business, and your patients. We’re committed to keeping you in the loop of key issues that can affect drug pricing and help you navigate them accordingly. Over the past year, Medicare...
Proposed Drug Pricing Rule – A Closer Look and its Potential Industry Impact
In November 2018, the Centers for Medicare and Medicaid Services (CMS) released a proposed rule called “Modernizing Part D and Medicare Advantage to Lower Drug Prices and Reduce Out-of-Pocket Expenses.” This proposed rule is comprised of several major provisions aimed...
Your Pharmacy’s Guide to Key Medicare Part D Changes in 2019 – Part 2
Welcome back to our discussion of 2019’s key changes in Medicare Part D, and how those changes are poised to impact the operations and relationships of independent pharmacies. In Part 1, we discussed the addition of new policies aimed at curtailing the opioid...